1. Home
  2. RYAM vs CADL Comparison

RYAM vs CADL Comparison

Compare RYAM & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

HOLD

Current Price

$8.42

Market Cap

661.8M

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$12.19

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAM
CADL
Founded
1926
1999
Country
United States
United States
Employees
2325
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
661.8M
694.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
RYAM
CADL
Price
$8.42
$12.19
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$14.00
$19.00
AVG Volume (30 Days)
930.0K
1.2M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
$1,466,397,000.00
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.92
$4.35
52 Week High
$11.85
$12.49

Technical Indicators

Market Signals
Indicator
RYAM
CADL
Relative Strength Index (RSI) 46.15 70.58
Support Level $8.03 $9.18
Resistance Level $8.80 N/A
Average True Range (ATR) 0.47 0.57
MACD -0.09 0.15
Stochastic Oscillator 7.91 93.71

Price Performance

Historical Comparison
RYAM
CADL

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: